OncoWest

What OncoWest does

OncoWest is a non-profit regional oncology network established in 2017 that coordinates multidisciplinary cancer care across six hospitals in West-Netherlands: Alrijne, Groene Hart, Haga, HMC, LUMC, and Reinier de Graaf. The network aligns these institutions around shared clinical protocols, multidisciplinary team (MDO) workflows, regional redistribution of oncological care, and patient-facing support services (including AYA, palliative, and psychological care), covering 10+ tumor types and collectively serving roughly 10% of all Dutch cancer patients.

The network's core technology stack centers on a digital collaboration layer built around the Vitaly MDO Portal (hosted on VECOZO), with Digital Pathology and XDS-based image exchange enabling cross-institutional case review. Compliance with the Dutch Integraal Zorgakkoord (IZA) framework and Soncos standards anchors the operating model, and LUMC's National Expertise Center recognition for Esophageal Carcinoma provides the academic referral tier underpinning complex case concentration.

OncoWest's business model is that of a publicly funded coordination entity rather than a commercial operator; it does not bill patients or sell software, and revenue mechanics are not disclosed. The 6-person core coordination team works alongside member-hospital staff, and the network's expansion is being driven through supra-regional collaborations (e.g., SWPCC for pancreatic cancer), concentration of complex care at designated centers (Upper-GI at LUMC and Reinier de Graaf), and broadening digital and patient-support services.

Name

OncoWest

Legal name

OncoWest

Website

https://oncowest.nl

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

OncoWest is a Dutch non-profit regional oncology network coordinating multidisciplinary cancer care across six West-Netherlands hospitals (including LUMC), covering 10+ tumor types and serving roughly 10% of Dutch cancer patients.

Ownership category

akta.pro rank

Product category

Regional Oncology Network Coordination

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults) (HLALABAI), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Regional oncology network
• Cancer care coordination
• Multidisciplinary oncology
• Hospital network collaboration
• Oncology care pathways

Headquarters

HQ city

Leiden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Public Healthcare Funding: OncoWest operates as a regional oncology network funded through public healthcare systems. The network coordinates care across six hospitals without generating direct revenue. Hospital collaborations are funded through standard Dutch healthcare financing mechanisms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

OncoWest is a regional oncology network coordinating cancer care delivery across six hospitals in West-Nederland (Alrijne, Groene Hart, HagaZiekenhuis, HMC, LUMC, and Reinier de Graaf). The network bundles knowledge and expertise, organizes multidisciplinary team meetings, develops shared care protocols, and runs digital initiatives such as the Vitaly MDO Portal, regional digital pathology, and the Trial Eye clinical-trial platform to ensure cancer patients receive standardized, high-quality care close to home when possible and centralized expertise when required.

Product overview

OncoWest is a regional oncology network (previously known as Regionaal Oncologienetwerk West or RO West) comprising 6 hospitals in West-Nederland that collaborate to provide coordinated, high-quality cancer care. The core offering is the network itself, which enables knowledge sharing, standardized care pathways, and quality monitoring across the region. Key digital products include the Vitaly MDO Portal for digital multidisciplinary team meetings and the Trial Eye study platform for clinical trial access. The network covers multiple tumor types (breast, colorectal, esophageal, pancreatic, prostate, gynecological, brain, head/neck, skin/melanoma, lung) and supports supporting care services including psychological support, AYA care for young adults, and palliative care. OncoWest treats approximately 10% of all cancer patients in the Netherlands.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Nearly 10% of all cancer patients in the Netherlands are treated within the OncoWest network
• +2 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

17 partnerships are on record, tiered core and supportive.

• Alrijne ZiekenhuiscoreStrategic or Co-development PartnerOne of six hospitals in the OncoWest network covering West-Nederland. Alrijne provides general oncology services and participates in network-wide protocols and MDO meetings for multiple tumor types.
• Groene Hart ZiekenhuiscoreStrategic or Co-development PartnerRegional hospital in Gouda participating in the OncoWest network, contributing to coordinated oncology care across the West-Nederland region.
• HagaZiekenhuiscoreStrategic or Co-development PartnerMajor hospital in The Hague contributing to the OncoWest network with particular expertise in areas including esophageal cancer Barrett surveillance and endoscopic treatments.
• Haaglanden Medisch Centrum (HMC)coreStrategic or Co-development PartnerMajor cancer treatment center in The Hague region, one of six core network hospitals providing comprehensive oncology services within OncoWest.
• Leids Universitair Medisch Centrum (LUMC)coreStrategic or Co-development PartnerAcademic medical center serving as the coordination hub for OncoWest. Hosts the regional bureau and serves as the primary surgical center for complex procedures including esophageal cancer. Recognized as National Expert Center for Esophageal Carcinoma.
• Reinier de Graaf GasthuiscoreStrategic or Co-development PartnerRegional hospital in Delft collaborating closely with LUMC. Together they form the Regional Expertise Center Upper-GI for esophageal and gastric cancer. Previously performed esophageal cancer surgeries, now concentrated at LUMC.
• HollandPTCcoreTechnology or IntegrationIndependent proton therapy center in Delft, founded by Erasmus MC, LUMC, and TU Delft. OncoWest refers appropriate patients for proton radiotherapy which offers more precise tumor targeting with less damage to surrounding healthy tissue for esophageal and gastric cancer patients.
• IPSO (Inloophuizen)supportiveStrategic or Co-development PartnerNational branch organization for cancer information and support centers. OncoWest lists regional IPSO centers (Carma, Debora, Marike, Samenhuis, Scarabee, Sentire) as resources for patients seeking psychological support, peer contact, and rehabilitation services.
• VECOZOcoreTechnology or IntegrationProvider of the Vitaly MDO Portal digital platform used for regional multidisciplinary team meetings. Enables healthcare professionals across six hospitals to efficiently plan, prepare, and document MDO meetings with improved information sharing.
• SleutelnetcoreImplementation/ SI/ Consulting PartnerRegional program coordinator for OncoWest, managing the implementation of the MDO Portal Vitaly project and coordinating network activities. Contact: Christi Ouwerkerk (program manager).
• Dutch Pancreatic Cancer Group (DPCG)coreStrategic or Co-development PartnerNational multidisciplinary collaboration of healthcare professionals focused on pancreatic cancer. SWPCC (collaboration of OncoWest, EMBRAZE, and Concord) connects with DPCG for clinical trial participation and research coordination.
• IKNL (Integraal Kankercentrum Nederland)supportiveStrategic or Co-development PartnerNational cancer center providing data, guidelines, and coordination for Dutch oncology care. Collaborated with all seven regional oncology networks on World Cancer Day 2026 prevention messaging.
• KWF KankerbestrijdingsupportiveStrategic or Co-development PartnerDutch Cancer Society supporting cancer research and prevention. Collaborated with regional oncology networks including OncoWest on World Cancer Day 2026 joint prevention campaign.
• Kanker.nlsupportiveStrategic or Co-development PartnerNational Dutch cancer information platform. Partnered with regional oncology networks for World Cancer Day 2026 joint prevention messaging about healthy lifestyle and early detection.
• SPKS (Stichting Patiënten met Kanker Spijsverteringskanaal)supportiveStrategic or Co-development PartnerPatient organization for esophageal and gastric cancer. Provides buddy support program, information, and peer contact. Works with LUMC and Reinier de Graaf on patient support and is consulted in the Expertisecentrum Zeldzame Aandoeningen certification.
• EMBRAZEcoreStrategic or Co-development PartnerOne of three oncology networks in the SWPCC (South West Pancreatic Cancer Care) collaboration, together with OncoWest and Concord, covering Southwest Netherlands for pancreatic cancer care.
• ConcordcoreStrategic or Co-development PartnerOne of three oncology networks in the SWPCC (South West Pancreatic Cancer Care) collaboration, together with OncoWest and EMBRAZE, covering Southwest Netherlands for pancreatic cancer care.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• HollandPTC: Independent proton therapy center in Delft, founded by Erasmus MC, LUMC, and TU Delft; OncoWest refers complex esophageal/gastric cancer patients to HollandPTC. Specialized but complementary player in Dutch oncology infrastructure.

Broad incumbents

• NCCN (National Comprehensive Cancer Network): US-based alliance of leading academic cancer centers producing oncology guidelines and coordinating research. Not a direct operational peer but thematically aligned as a multi-institution cancer coordination organization.
• IKNL (Integraal Kankercentrum Nederland): National Dutch cancer registry and coordination organization; collaborates with all seven regional oncology networks (including OncoWest) but operates at the national rather than regional level, providing data, guidelines, and quality monitoring.
• Santeon: Group of seven leading Dutch hospitals that collaborate on value-based care improvement, including oncology. Comparable to OncoWest as a hospital-collaboration vehicle but broader in scope (multiple conditions, single organization).
• UNICANCER: French federation of Comprehensive Cancer Centers (CLCCs) coordinating cancer care, research, and innovation across 18 hospitals. Functionally analogous to OncoWest at a national scale — a hospital-network coordination entity focused exclusively on oncology.
• NHS Cancer Alliances (UK): Regional cancer care coordination entities in England that bring together NHS hospitals, primary care, and other partners to deliver improved cancer outcomes. Comparable structural model to OncoWest (multi-hospital coordination under a regional footprint) operating within a different national healthcare system.

Direct peers

• EMBRAZE: Regional oncology network in the Netherlands; a direct comparable to OncoWest and a current partner in the SWPCC supra-regional pancreatic cancer collaboration. Operates the same model of hospital-based oncology coordination across multiple institutions in an adjacent Dutch region.
• Concord (Regionaal Oncologienetwerk Concord): Dutch regional oncology network partnering with OncoWest in SWPCC. Closely comparable coordination entity linking hospitals for multidisciplinary oncology care under the same IZA framework.
• OncoZWN: Regional oncology network in Zeeland and West-Brabant operating the same multi-hospital coordination model as OncoWest under the Dutch IZA framework. Comparable size and structure.

Regional players

• Dutch Pancreatic Cancer Group (DPCG): National Dutch multidisciplinary collaboration focused on pancreatic cancer; OncoWest's SWPCC collaboration feeds into DPCG for clinical trials and research. Comparable coordination-focused entity but with national scope and a single-tumor focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oncowest

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OncoWest